Metraipolis › archive › dc_f005b86fae86

Lenacapavir-induced lattice hyperstabilization is central to HIV-1 capsid failure at the nuclear pore complex and in the cytoplasm — Europe PMC PMID:42417517

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42417517
DOI
10.7554/elife.109282
License (as archived)
CC0-1.0
Archived
2026-10-06T07:56:25.075Z
SHA-256 of the archived text
1e6ceebe58de1801855cbe63e547f248a4d42bd3df20a27012fafa36fb058dfc
Stable URL of this page
https://metraipolis.com/documento/dc_f005b86fae86

How to cite

Lenacapavir-induced lattice hyperstabilization is central to HIV-1 capsid failure at the nuclear pore complex and in the cytoplasm — Europe PMC PMID:42417517 — Europe PMC (en), https://europepmc.org/article/MED/42417517 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f005b86fae86 (Metraipolis archive dc_f005b86fae86, sha256 1e6ceebe58de1801855cbe63e547f248a4d42bd3df20a27012fafa36fb058dfc)
BibTeX
@misc{dcf005b86fae86,
  title = {Lenacapavir-induced lattice hyperstabilization is central to HIV-1 capsid failure at the nuclear pore complex and in the cytoplasm — Europe PMC PMID:42417517},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42417517},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f005b86fae86; sha256 1e6ceebe58de1801855cbe63e547f248a4d42bd3df20a27012fafa36fb058dfc},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/42417517. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Lenacapavir (LEN) is the first human immunodeficiency virus type 1 (HIV-1) capsid inhibitor approved for clinical use in humans. It inhibits multiple steps of the viral life cycle; however, the molecular details of the effect of LEN on capsid structure and the mechanistic steps of the inhibition are not understood. Recent studies show that intact cone-shaped capsids and capsids with LEN-induced breaks can dock at nuclear pore complexes (NPCs), but only intact capsids enter the nucleus. In this work, we combined large-scale coarse-grained molecular dynamics simulations and live-cell imaging to investigate the stepwise mechanism of docking of LEN-treated capsids into the NPC. Capsids bound to substoichiometric concentrations of LEN can reach the NPC central channel. As the capsid advances to the nuclear end, lattice defects are formed at the pentamer-hexamer interface - primarily at the narrower end - leading to pentamer dissociation. Dissociation of pentamers is detrimental to capsid integrity, leading to both rupture of the narrow end and destabilization of the hexamer-hexamer interface. Structural analysis of LEN-capsid complexes in our simulations demonstrates heterogeneous hyperstabilization and loss of the essential pliability of the capsid protein lattice. Live-cell imaging of HIV-1 cores labeled with two different fluorescent markers showed that LEN-treated ruptured capsids were docked at the NPC but were not imported into the nucleus. We conclude that LEN contributes to the loss of capsid elasticity and integrity, inhibiting HIV-1 nuclear entry and replication. Our findings demonstrate that altering viral material properties can be an effective strategy for designing human antiviral drugs.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: eLife, 2026 (prima pubblicazione 2026-07-08).
Identificativi: PMID 42417517 · PMCID PMC13345633 · DOI 10.7554/elife.109282.
Parole chiave degli autori: Human; Simulation; HIV; Capsid; Structural Biology; Coarse-graining; Molecular Biophysics; Lenacapavir.
Descrittori MeSH principali: Nuclear Pore; Cytoplasm; HIV-1; Capsid; Quinolones; Anti-HIV Agents.
Pagina: https://europepmc.org/article/MED/42417517 — https://doi.org/10.7554/elife.109282. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T07:47:50.228Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.